Risk of dementia in diabetes mellitus: a systematic review (Q36345254)

13 August 2017

1 reference

title

Risk of dementia in diabetes mellitus: a systematic review (English)

1 reference

13 August 2017

0 references

1 reference

Philip Scheltens

1 reference

13 August 2017

Carol Brayne

1 reference

13 August 2017

Geert Jan Biessels

1 reference

13 August 2017

Salka Staekenborg

1 reference

13 August 2017

Eric Brunner

series ordinal

1 reference

13 August 2017

publication date

1 January 2006

1 reference

13 August 2017

1 reference

13 August 2017

1 reference

13 August 2017

1 reference

13 August 2017

page(s)

64-74

1 reference

The effects of type 1 diabetes on cognitive performance: a meta-analysis.

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970284-2

7 January 2021

The relationship between impaired glucose tolerance, type 2 diabetes, and cognitive function

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970284-2

7 January 2021

Type 2 diabetes mellitus, cognitive impairment and dementia.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970284-2

7 January 2021

Is type II diabetes associated with an increased risk of cognitive dysfunction? A critical review of published studies

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970284-2

7 January 2021

The relationship between type 2 diabetes and cognitive dysfunction: longitudinal studies and their methodological limitations

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970284-2

7 January 2021

Comorbid type 2 diabetes mellitus and hypertension exacerbates cognitive decline: evidence from a longitudinal study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970284-2

7 January 2021

Change in cognitive function by glucose tolerance status in older adults: a 4-year prospective study of the Rancho Bernardo study cohort

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970284-2

7 January 2021

Apolipoprotein-E genotyping of diabetic dementia patients: is diabetes rare in Alzheimer's disease?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970284-2

7 January 2021

Changes in blood glucose and insulin secretion in patients with senile dementia of Alzheimer type.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970284-2

7 January 2021

Are Alzheimer patients healthier?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970284-2

7 January 2021

Increased risk of type 2 diabetes in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970284-2

7 January 2021

Modulation of memory by insulin and glucose: neuropsychological observations in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970284-2

7 January 2021

Global and societal implications of the diabetes epidemic

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970284-2

7 January 2021

Development of dementing illnesses in an 80-year-old volunteer cohort

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970284-2

7 January 2021

Incidence and risk factors of vascular dementia and Alzheimer's disease in a defined elderly Japanese population: the Hisayama Study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970284-2

7 January 2021

Risk of dementia among persons with diabetes mellitus: a population-based cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970284-2

7 January 2021

Vascular risks and incident dementia: results from a cohort study of the very old.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970284-2

7 January 2021

Diabetes mellitus and the risk of dementia: The Rotterdam Study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970284-2

7 January 2021

Longitudinal association of vascular and Alzheimer's dementias, diabetes, and glucose tolerance.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970284-2

7 January 2021

Diabetes mellitus and risk of Alzheimer's disease and dementia with stroke in a multiethnic cohort

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970284-2

7 January 2021

Diabetes mellitus is a risk factor for vascular dementia, but not for Alzheimer's disease: a population-based study of the oldest old.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970284-2

7 January 2021

Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: The Honolulu-Asia Aging Study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970284-2

7 January 2021

Diabetes mellitus and the risk of dementia, Alzheimer's disease and vascular cognitive impairment in the Canadian Study of Health and Aging

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970284-2

7 January 2021

Association between dementia and midlife risk factors: the Radiation Effects Research Foundation Adult Health Study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970284-2

7 January 2021

Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970284-2

7 January 2021

Diabetes mellitus in midlife and the risk of dementia three decades later

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970284-2

7 January 2021

Diabetes mellitus and risk of dementia in the Kungsholmen project: a 6-year follow-up study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970284-2

7 January 2021

Aggregation of vascular risk factors and risk of incident Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970284-2

7 January 2021

Midlife cardiovascular risk factors and risk of dementia in late life

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970284-2

7 January 2021

Vascular dementia : incidence and risk factors in the Canadian study of health and aging

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970284-2

7 January 2021

Risk factors for Alzheimer's disease: a prospective analysis from the Canadian Study of Health and Aging.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970284-2

7 January 2021

Hyperinsulinemia and risk of Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970284-2

7 January 2021

Incidence of AD in African-Americans, Caribbean Hispanics, and Caucasians in northern Manhattan

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970284-2

7 January 2021

Quality of reporting of observational longitudinal research.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970284-2

7 January 2021

Meta-analysis of Observational Studies in Epidemiology: A Proposal for Reporting

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970284-2

7 January 2021

A systematic literature review of attrition between waves in longitudinal studies in the elderly shows a consistent pattern of dropout between differing studies.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970284-2

7 January 2021

Trends in the prevalence and ratio of diagnosed to undiagnosed diabetes according to obesity levels in the U.S.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970284-2

7 January 2021

Prevalence of undiagnosed Type 2 diabetes and impaired fasting glucose in older British men and women

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970284-2

7 January 2021

Incidence, prevalence, and mortality of diabetes in a large population. A report from the Skaraborg Diabetes Registry

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970284-2

7 January 2021

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970284-2

7 January 2021

Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970284-2

7 January 2021

Practice parameter: diagnosis of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970284-2

7 January 2021

Clinicopathological Validation Study of Four Sets of Clinical Criteria for Vascular Dementia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970284-2

7 January 2021

The validity and reliability of 6 sets of clinical criteria to classify Alzheimer's disease and vascular dementia in cases confirmed post-mortem: added value of a decision tree approach

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970284-2

7 January 2021

Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer's Disease Diagnostic and Treatment Centers

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970284-2

7 January 2021

The age-dependent relation of blood pressure to cognitive function and dementia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970284-2

7 January 2021

Vascular risk factors for Alzheimer's disease: an epidemiologic perspective.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970284-2

7 January 2021

Central Nervous System Findings in a Tenth Decade Autopsy Population

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970284-2

7 January 2021

Diabetics do not have increased Alzheimer-type pathology compared with age-matched control subjects. A retrospective postmortem immunocytochemical and histofluorescent study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970284-2

7 January 2021

Type 2 diabetes is negatively associated with Alzheimer's disease neuropathology

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970284-2

7 January 2021

Neuropathological stageing of Alzheimer-related changes

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970284-2

7 January 2021

Lacunar infarcts defined by magnetic resonance imaging of 3660 elderly people: the Cardiovascular Health Study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970284-2

7 January 2021

Incidence and risk factors of silent brain infarcts in the population-based Rotterdam Scan Study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970284-2

7 January 2021

Type 2 diabetes and atrophy of medial temporal lobe structures on brain MRI.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970284-2

7 January 2021

Magnetic resonance imaging of the brain in diabetes: the Cardiovascular Determinants of Dementia (CASCADE) Study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970284-2

7 January 2021

MRI of the brain in diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970284-2

7 January 2021

Structural magnetic resonance imaging in the practical assessment of dementia: beyond exclusion

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970284-2

7 January 2021

Magnetic resonance imaging signal hyperintensities in the deep and subcortical white matter. A comparative study between stroke patients and normal volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970284-2

7 January 2021

Cognition and synaptic plasticity in diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970284-2

7 January 2021

Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales. Neuropathology Group of the Medical Research Council Cognitive Function and Ageing Study (MRC CFAS).

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970284-2

7 January 2021

Stroke in patients with diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970284-2

7 January 2021

The independent effect of type 2 diabetes mellitus on ischemic heart disease, stroke, and death: a population-based study of 13,000 men and women with 20 years of follow-up.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970284-2

7 January 2021

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970284-2

7 January 2021

Invited commentary: insulin resistance syndrome? Syndrome X? Multiple metabolic syndrome? A syndrome at all? Factor analysis reveals patterns in the fabric of correlated metabolic risk factors

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970284-2

7 January 2021

Association between features of the insulin resistance syndrome and Alzheimer's disease independently of apolipoprotein E4 phenotype: cross sectional population based study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970284-2

7 January 2021

Metabolic cardiovascular syndrome and risk of dementia in Japanese-American elderly men. The Honolulu-Asia aging study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970284-2

7 January 2021

Glucose intolerance, hyperinsulinaemia and cognitive function in a general population of elderly men

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970284-2

7 January 2021

The metabolic syndrome, inflammation, and risk of cognitive decline

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970284-2

7 January 2021

Insulin resistance and risk for stroke

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970284-2

7 January 2021

Ageing and diabetes: implications for brain function

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970284-2

7 January 2021

Place learning and hippocampal synaptic plasticity in streptozotocin-induced diabetic rats.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970284-2

7 January 2021

Biochemistry and molecular cell biology of diabetic complications

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970284-2

7 January 2021

Cognitive consequences of thalamic, basal ganglia, and deep white matter lacunes in brain aging and dementia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970284-2

7 January 2021

Cerebrovascular pathology and dementia in autopsied Honolulu-Asia Aging Study participants

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970284-2

7 January 2021

Radical AGEing in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970284-2

7 January 2021

Critically attained threshold of cerebral hypoperfusion: the CATCH hypothesis of Alzheimer's pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970284-2

7 January 2021

Brain insulin and feeding: a bi-directional communication

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970284-2

7 January 2021

Amyloid beta antagonizes insulin promoted secretion of the amyloid beta protein precursor.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970284-2

7 January 2021

Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970284-2

7 January 2021

The source of cerebral insulin

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970284-2

7 January 2021

Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease – is this type 3 diabetes?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970284-2

7 January 2021

Signaling by insulin-like growth factor 1 in brain

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970284-2

7 January 2021

Role of insulin and insulin receptor in learning and memory

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970284-2

7 January 2021

Brain insulin and insulin receptors in aging and sporadic Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970284-2

7 January 2021

Age- and region-dependent alterations in Abeta-degrading enzymes: implications for Abeta-induced disorders

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970284-2

7 January 2021

Insulin and neurodegenerative disease: shared and specific mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970284-2

7 January 2021

Potential roles of insulin and IGF-1 in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970284-2

7 January 2021

Reduced hippocampal insulin-degrading enzyme in late-onset Alzheimer's disease is associated with the apolipoprotein E-epsilon4 allele

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970284-2

7 January 2021

Emerging therapies for vascular dementia and vascular cognitive impairment

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970284-2

7 January 2021

10.1016/S1474-4422(05)70284-2

Identifiers

DOI

1 reference

13 August 2017

1 reference